Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases

Figure 1

Validation of the antibodies used for application in RPMA. 30–40 μg of protein derived from human muscle (M) were fractionated on SDS-PAGE gels (see Coomasie blue stained track on top-left), blotted against the indicated antibodies and processed for western blotting. Only antibodies that recognize a single protein band of the expected molecular mass were used in the study. The migration of molecular mass markers is indicated to the left.

Back to article page